Alexandra Drakaki, MD, PhD, Author at Grand Rounds in Urology

Alexandra Drakaki, MD, PhD

Alexandra Drakaki, MD, PhD, received her training in Internal Medicine at a Tuft's University affiliate program while she completed her Hematology / Oncology training at Beth Israel Deaconess Medical Center at Harvard Medical School and her research fellowship at Dana Farber Cancer Center Harvard Medical School in Boston. Dr. Drakaki is currently an associate professor of Hematology/Oncology and Urology at the University of California, Los Angeles.

Dr. Drakaki specializes in Genitourinary cancers and specifically cancers of the Bladder, Kidney, Prostate and Testicles. She is the Primary Investigator in therapeutic clinical trials as well as the Lead investigator at a national level in studies that are testing novel drugs. Her research interest is studying the role of a class of genes, named non-coding RNAs, including microRNAs and linkRNAs in genitourinary malignancies. Dr. Drakaki also has a special interest in studying and understanding the mechanism of drug related toxicity with the goal to find combinations of medications that reverse/prevent toxicity without stopping effective therapies.

Dr. Drakaki is part of the Translational Oncology Research Laboratory of the globally renowned Dr. Slamon, in which researchers are working on drug development by using novel technologies for breakthrough discoveries to treat cancer.

Talks by Alexandra Drakaki, MD, PhD

Role of CtDNA in Bladder Cancer

Posted by Alexandra Drakaki, MD, PhD | Mar 2025

Alexandra Drakaki, MD, PhD, explores circulating tumor DNA in bladder cancer, highlighting its potential as a biomarker.